LIVIVO - Search results -

Search results

Result 1 - 10 of total 28

Search options

Article ; Online: Correction: Billeaud et al. "Effects on Fatty Acid Metabolism of a New Powdered Human Milk Fortifier Containing Medium-Chain Triacylglycerols and Docosahexaenoic Acid in Preterm Infants"

Billeaud, Claude / Boué-Vaysse, Carole / Couëdelo, Leslie / Steenhout, Philippe / Jaeger, Jonathan / Cruz-Hernandez, Cristina / Ameye, Laurent / Rigo, Jacques / Picaud, Jean-Charles / Saliba, Elie / Hays, Nicholas P / Destaillats, Frédéric

Nutrients

2019 Volume 11, Issue 3

Abstract: The authors wish to make a correction to the published version of their paper [ ... ]. ...

Abstract	The authors wish to make a correction to the published version of their paper [...].
Language	English
Publishing date	2019-03-22
Publishing country	Switzerland
Document type	Published Erratum
ZDB-ID	2518386-2
ISSN	2072-6643 ; 2072-6643
ISSN (online)	2072-6643
ISSN	2072-6643
DOI	10.3390/nu11030680
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Recurrence and Outcome of Anti-Glomerular Basement Membrane Glomerulonephritis After Kidney Transplantation.

Coche, Sophie / Sprangers, Ben / Van Laecke, Steven / Weekers, Laurent / De Meyer, Vicky / Hellemans, Rachel / Castanares, Diego / Ameye, Heleen / Goffin, Eric / Demoulin, Nathalie / Gillion, Valentine / Mourad, Michel / Darius, Tom / Buemi, Antoine / Devresse, Arnaud / Kanaan, Nada

Kidney international reports

2021 Volume 6, Issue 7, Page(s) 1888–1894

Abstract: Introduction: Recurrence of anti-glomerular basement membrane (anti-GBM) glomerulonephritis in the kidney graft is a rare event, described in limited reports. The aim of this study was to evaluate, in a large cohort of patients with long follow-up, the ... ...

Abstract	Introduction: Recurrence of anti-glomerular basement membrane (anti-GBM) glomerulonephritis in the kidney graft is a rare event, described in limited reports. The aim of this study was to evaluate, in a large cohort of patients with long follow-up, the risk of recurrence of anti-GBM disease, the risk factors associated with clinical recurrence, and the long-term patient and graft survival. Methods: This was a multicenter retrospective study. Inclusion criteria were patients with anti-GBM glomerulonephritis who underwent transplantation of a kidney between 1977 and 2015. Exclusion criteria were systemic vasculitis, lupus erythematosus, and cryoglobulinemia. Recurrence was defined as reappearance of clinical signs of glomerulonephritis along with histological signs of proliferative glomerulonephritis and linear IgG staining on kidney biopsy, with or without anti-GBM antibodies. Results: A total of 53 patients were included. Recurrence of anti-GBM glomerulonephritis in a first kidney transplant occurred in only 1 patient 5 years after transplantation (a prevalence rate of 1.9%) in the context of cessation of immunosuppressive drugs, and resulted in graft loss due to recurrence. Linear IgG staining on kidney biopsy in the absence of histological signs of proliferative glomerulonephritis was observed in 4 patients, in the context of cellular rejection. Patient survival was 100%, 94%, and 89% at 5, 10, and 15 years, respectively. Death-censored first-graft survival rates were 88%, 83%, and 79% at 5, 10, and 15 years, respectively. Conclusion: The recurrence rate of anti-GBM glomerulonephritis after transplantation is very low but is associated with graft loss. The long-term patient and graft survival rates are excellent.
Language	English
Publishing date	2021-04-28
Publishing country	United States
Document type	Journal Article
ISSN	2468-0249
ISSN (online)	2468-0249
DOI	10.1016/j.ekir.2021.04.011
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Reply: "Letter to the Editor Re: Billeaud et al.

Nutrients

2019 Volume 11, Issue 2

Abstract: We thank Bernard and colleagues for their careful reading and interest in our ... ...

Abstract	We thank Bernard and colleagues for their careful reading and interest in our article
MeSH term(s)	Arachidonic Acid ; Docosahexaenoic Acids ; Humans ; Infant ; Infant, Newborn ; Infant, Premature ; Milk, Human ; Nutrients
Chemical Substances	Nutrients ; Docosahexaenoic Acids (25167-62-8) ; Arachidonic Acid (27YG812J1I)
Language	English
Publishing date	2019-02-15
Publishing country	Switzerland
Document type	Letter
ZDB-ID	2518386-2
ISSN	2072-6643 ; 2072-6643
ISSN (online)	2072-6643
ISSN	2072-6643
DOI	10.3390/nu11020406
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.

Cancer medicine

2021 Volume 10, Issue 13, Page(s) 4366–4374

Abstract: Background: While docetaxel/cisplatin/5-fluorouracil (DCF) outperforms CF in first-line gastric adenocarcinoma, toxicity remains an issue.: Methods: This multicenter phase II trial randomized chemonaïve metastatic gastric adenocarcinoma patients to ... ...

Abstract	Background: While docetaxel/cisplatin/5-fluorouracil (DCF) outperforms CF in first-line gastric adenocarcinoma, toxicity remains an issue. Methods: This multicenter phase II trial randomized chemonaïve metastatic gastric adenocarcinoma patients to fractionated weekly DCF (D 40 mg/m Results: A total of 106 eligible patients were recruited. The early and overall FN rates were 9.5% and 17% in arm 1, respectively, and 5.9% and 8% in arm 2, respectively. Grade ≥3 toxicities occurred in 81% of patients in arm 1 and 90% of patients in arm 2, the most common being neutropenia (33% vs. 61%), fatigue (27% vs. 25%), vomiting (21% vs. 12%), anorexia (19% vs. 18%), and diarrhea (17% vs. 10%). Median progression-free survival and overall survival were 5.1 (95% CI, 3.2-6.5) and 8.2 months (95% CI, 6.0-14.5), respectively, in arm 1 and 5.2 (95% CI, 3.0-6.9) and 11.9 months (95% CI, 7.4-15.9), respectively, in arm 2. Conclusions: Fractionated weekly and fortnightly DCF regimens are associated with a low risk of early FN, and a better hematological toxicity profile as compared to historical DCF without compromising efficacy. Both regimens offer greater convenience removing the need for systematic use of prophylactic G-CSF.
MeSH term(s)	Adenocarcinoma/drug therapy ; Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adult ; Aged ; Aged, 80 and over ; Anorexia/chemically induced ; Anorexia/epidemiology ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cisplatin/administration & dosage ; Cisplatin/adverse effects ; Diarrhea/chemically induced ; Diarrhea/epidemiology ; Docetaxel/administration & dosage ; Docetaxel/adverse effects ; Drug Administration Schedule ; Esophagogastric Junction ; Fatigue/chemically induced ; Fatigue/epidemiology ; Febrile Neutropenia/epidemiology ; Female ; Fluorouracil/administration & dosage ; Fluorouracil/adverse effects ; Granulocyte Colony-Stimulating Factor ; Humans ; Male ; Middle Aged ; Neutropenia/chemically induced ; Neutropenia/epidemiology ; Progression-Free Survival ; Stomach Neoplasms/drug therapy ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology ; Vomiting/chemically induced ; Vomiting/epidemiology
Chemical Substances	Granulocyte Colony-Stimulating Factor (143011-72-7) ; Docetaxel (15H5577CQD) ; Cisplatin (Q20Q21Q62J) ; Fluorouracil (U3P01618RT)
Language	English
Publishing date	2021-05-31
Publishing country	United States
Document type	Clinical Trial, Phase II ; Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
ZDB-ID	2659751-2
ISSN	2045-7634 ; 2045-7634
ISSN (online)	2045-7634
ISSN	2045-7634
DOI	10.1002/cam4.3976
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Carnosol Inhibits Pro-Inflammatory and Catabolic Mediators of Cartilage Breakdown in Human Osteoarthritic Chondrocytes and Mediates Cross-Talk between Subchondral Bone Osteoblasts and Chondrocytes.

Sanchez, Christelle / Horcajada, Marie-Noëlle / Membrez Scalfo, Fanny / Ameye, Laurent / Offord, Elizabeth / Henrotin, Yves

PloS one

2015 Volume 10, Issue 8, Page(s) e0136118

Abstract: Aim: The aim of this work was to evaluate the effects of carnosol, a rosemary polyphenol, on pro-inflammatory and catabolic mediators of cartilage breakdown in chondrocytes and via bone-cartilage crosstalk.: Materials and methods: Osteoarthritic (OA) ...

Abstract	Aim: The aim of this work was to evaluate the effects of carnosol, a rosemary polyphenol, on pro-inflammatory and catabolic mediators of cartilage breakdown in chondrocytes and via bone-cartilage crosstalk. Materials and methods: Osteoarthritic (OA) human chondrocytes were cultured in alginate beads for 4 days in presence or absence of carnosol (6 nM to 9 μM). The production of aggrecan, matrix metalloproteinase (MMP)-3, tissue inhibitor of metalloproteinase (TIMP)-1, interleukin (IL)-6 and nitric oxide (NO) and the expression of type II collagen and ADAMTS-4 and -5 were analyzed. Human osteoblasts from sclerotic (SC) or non-sclerotic (NSC) subchondral bone were cultured for 3 days in presence or absence of carnosol before co-culture with chondrocytes. Chondrocyte gene expression was analyzed after 4 days of co-culture. Results: In chondrocytes, type II collagen expression was significantly enhanced in the presence of 3 μM carnosol (p = 0.008). MMP-3, IL-6, NO production and ADAMTS-4 expression were down-regulated in a concentration-dependent manner by carnosol (p<0.01). TIMP-1 production was slightly increased at 3 μM (p = 0.02) and ADAMTS-5 expression was decreased from 0.2 to 9 μM carnosol (p<0.05). IL-6 and PGE2 production was reduced in the presence of carnosol in both SC and NSC osteoblasts while alkaline phosphatase activity was not changed. In co-culture experiments preincubation of NSC and SC osteoblasts wih carnosol resulted in similar effects to incubation with anti-IL-6 antibody, namely a significant increase in aggrecan and decrease in MMP-3, ADAMTS-4 and -5 gene expression by chondrocytes. Conclusions: Carnosol showed potent inhibition of pro-inflammatory and catabolic mediators of cartilage breakdown in chondrocytes. Inhibition of matrix degradation and enhancement of formation was observed in chondrocytes cocultured with subchondral osteoblasts preincubated with carnosol indicating a cross-talk between these two cellular compartments, potentially mediated via inhibition of IL-6 in osteoblasts as similar results were obtained with anti-IL-6 antibody.
MeSH term(s)	Aggrecans/immunology ; Anti-Inflammatory Agents/pharmacology ; Cell Survival/drug effects ; Cells, Cultured ; Chondrocytes/drug effects ; Chondrocytes/immunology ; Chondrocytes/pathology ; Coculture Techniques ; Dinoprostone/immunology ; Diterpenes, Abietane/pharmacology ; Humans ; Interleukin-6/immunology ; Matrix Metalloproteinase 3/immunology ; Osteoarthritis/drug therapy ; Osteoarthritis/immunology ; Osteoarthritis/pathology ; Osteoblasts/drug effects ; Osteoblasts/immunology ; Osteoblasts/pathology ; Tissue Inhibitor of Metalloproteinase-1/immunology
Chemical Substances	Aggrecans ; Anti-Inflammatory Agents ; Diterpenes, Abietane ; Interleukin-6 ; Tissue Inhibitor of Metalloproteinase-1 ; carnosol (483O455CKD) ; MMP3 protein, human (EC 3.4.24.17) ; Matrix Metalloproteinase 3 (EC 3.4.24.17) ; Dinoprostone (K7Q1JQR04M)
Language	English
Publishing date	2015
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ISSN	1932-6203
ISSN (online)	1932-6203
DOI	10.1371/journal.pone.0136118
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Full text

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾
- Full text online
- Order with fees

Article: Animal models of osteoarthritis: lessons learned while seeking the "Holy Grail".

Ameye, Laurent G / Young, Marian F

Current opinion in rheumatology

2006 Volume 18, Issue 5, Page(s) 537–547

Abstract: Purpose of review: Difficulties in studying osteoarthritis in humans that stem from both the low sensitivity of diagnostic tools and the low availability of diseased tissues explain why research on animal models remains highly dynamic. This review will ... ...

Abstract	Purpose of review: Difficulties in studying osteoarthritis in humans that stem from both the low sensitivity of diagnostic tools and the low availability of diseased tissues explain why research on animal models remains highly dynamic. This review will summarize the recent advances in this field. Recent findings: With regard to the etiology of osteoarthritis, synovial macrophages mediate osteophyte formation, whereas increased ligament laxity could be responsible for spontaneous osteoarthritis in guinea pigs. The concomitant changes in subchondral bone and cartilage reported in several models, and the structure-modifying effects of some bone inhibitors have confirmed the importance of bone in osteoarthritis. With regard to cartilage pathobiology, ADAMTS-5 is the major aggrecanase responsible for cartilage destruction, whereas inadequate control of oxidative stress and decreased expression of transforming growth factor-beta receptors could predispose to osteoarthritis. New models include a postmenopausal rat model, the groove model and a joint-specific bone morphogenetic receptor-deficient mouse. The iodoacetate model was also validated as the first pain model of osteoarthritis. Summary: In view of the multiple animal models available, there is a need to reach a consensus on one or several gold standard animal model(s). New studies indicate that important differences in therapeutic response exist between young and old animals, and between spontaneous and surgical models, suggesting that not all models are adequate models of osteoarthritis.
MeSH term(s)	ADAM Proteins/metabolism ; ADAMTS5 Protein ; Animals ; Bone and Bones/metabolism ; Bone and Bones/pathology ; Cartilage/metabolism ; Cartilage/pathology ; Disease Models, Animal ; Gene Expression Regulation ; Guinea Pigs ; Humans ; Mice ; Mice, Transgenic ; Osteoarthritis/diagnosis ; Osteoarthritis/etiology ; Osteoarthritis/metabolism ; Osteoarthritis/pathology ; Osteoarthritis/therapy ; Oxidative Stress ; Pain/chemically induced ; Pain/metabolism ; Pain/pathology ; Pain Management ; Rats ; Transforming Growth Factor beta/biosynthesis
Chemical Substances	Transforming Growth Factor beta ; ADAM Proteins (EC 3.4.24.-) ; ADAMTS5 Protein (EC 3.4.24.-) ; ADAMTS5 protein, human (EC 3.4.24.-)
Language	English
Publishing date	2006-09
Publishing country	United States
Document type	Journal Article ; Review
ZDB-ID	1045317-9
ISSN	1531-6963 ; 1040-8711
ISSN (online)	1531-6963
ISSN	1040-8711
DOI	10.1097/01.bor.0000240369.39713.af
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 3028: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Effects on Fatty Acid Metabolism of a New Powdered Human Milk Fortifier Containing Medium-Chain Triacylglycerols and Docosahexaenoic Acid in Preterm Infants.

Nutrients

2018 Volume 10, Issue 6

Abstract: Preterm infants require fortification of human milk (HM) with essential fatty acids (FA) to ensure adequate post-natal development. As part of a larger randomized controlled study, we investigated FA metabolism in a subset of 47 clinically stable preterm ...

Abstract	Preterm infants require fortification of human milk (HM) with essential fatty acids (FA) to ensure adequate post-natal development. As part of a larger randomized controlled study, we investigated FA metabolism in a subset of 47 clinically stable preterm infants (birth weight ≤1500 g or gestational age ≤32 weeks). Infants were randomized to receive HM supplemented with either a new HM fortifier (nHMF;
MeSH term(s)	Arachidonic Acid/blood ; Dietary Carbohydrates/administration & dosage ; Dietary Fats/administration & dosage ; Dietary Proteins/administration & dosage ; Docosahexaenoic Acids/administration & dosage ; Docosahexaenoic Acids/blood ; Double-Blind Method ; Erythrocytes/metabolism ; Fatty Acids, Essential/administration & dosage ; Fatty Acids, Essential/blood ; Fatty Acids, Monounsaturated/blood ; Female ; Food, Fortified/analysis ; Humans ; Infant Formula/chemistry ; Infant, Newborn ; Infant, Premature/blood ; Infant, Premature/growth & development ; Linoleic Acid/administration & dosage ; Linoleic Acid/blood ; Lipid Metabolism ; Male ; Milk, Human ; Phosphatidylcholines/blood ; Phosphatidylethanolamines/blood ; Powders ; Triglycerides/administration & dosage ; Triglycerides/blood ; alpha-Linolenic Acid/administration & dosage ; alpha-Linolenic Acid/blood
Chemical Substances	Dietary Carbohydrates ; Dietary Fats ; Dietary Proteins ; Fatty Acids, Essential ; Fatty Acids, Monounsaturated ; Phosphatidylcholines ; Phosphatidylethanolamines ; Powders ; Triglycerides ; alpha-Linolenic Acid (0RBV727H71) ; Docosahexaenoic Acids (25167-62-8) ; Arachidonic Acid (27YG812J1I) ; phosphatidylethanolamine (39382-08-6) ; Linoleic Acid (9KJL21T0QJ)
Language	English
Publishing date	2018-05-29
Publishing country	Switzerland
Document type	Journal Article ; Multicenter Study ; Randomized Controlled Trial
ZDB-ID	2518386-2
ISSN	2072-6643 ; 2072-6643
ISSN (online)	2072-6643
ISSN	2072-6643
DOI	10.3390/nu10060690
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Carnosol Inhibits Pro-Inflammatory and Catabolic Mediators of Cartilage Breakdown in Human Osteoarthritic Chondrocytes and Mediates Cross-Talk between Subchondral Bone Osteoblasts and Chondrocytes.

Christelle Sanchez / Marie-Noëlle Horcajada / Fanny Membrez Scalfo / Laurent Ameye / Elizabeth Offord / Yves Henrotin

PLoS ONE, Vol 10, Iss 8, p e

2015 Volume 0136118

Abstract: The aim of this work was to evaluate the effects of carnosol, a rosemary polyphenol, on pro-inflammatory and catabolic mediators of cartilage breakdown in chondrocytes and via bone-cartilage crosstalk.Osteoarthritic (OA) human chondrocytes were cultured ... ...

Abstract	The aim of this work was to evaluate the effects of carnosol, a rosemary polyphenol, on pro-inflammatory and catabolic mediators of cartilage breakdown in chondrocytes and via bone-cartilage crosstalk.Osteoarthritic (OA) human chondrocytes were cultured in alginate beads for 4 days in presence or absence of carnosol (6 nM to 9 μM). The production of aggrecan, matrix metalloproteinase (MMP)-3, tissue inhibitor of metalloproteinase (TIMP)-1, interleukin (IL)-6 and nitric oxide (NO) and the expression of type II collagen and ADAMTS-4 and -5 were analyzed. Human osteoblasts from sclerotic (SC) or non-sclerotic (NSC) subchondral bone were cultured for 3 days in presence or absence of carnosol before co-culture with chondrocytes. Chondrocyte gene expression was analyzed after 4 days of co-culture.In chondrocytes, type II collagen expression was significantly enhanced in the presence of 3 μM carnosol (p = 0.008). MMP-3, IL-6, NO production and ADAMTS-4 expression were down-regulated in a concentration-dependent manner by carnosol (p<0.01). TIMP-1 production was slightly increased at 3 μM (p = 0.02) and ADAMTS-5 expression was decreased from 0.2 to 9 μM carnosol (p<0.05). IL-6 and PGE2 production was reduced in the presence of carnosol in both SC and NSC osteoblasts while alkaline phosphatase activity was not changed. In co-culture experiments preincubation of NSC and SC osteoblasts wih carnosol resulted in similar effects to incubation with anti-IL-6 antibody, namely a significant increase in aggrecan and decrease in MMP-3, ADAMTS-4 and -5 gene expression by chondrocytes.Carnosol showed potent inhibition of pro-inflammatory and catabolic mediators of cartilage breakdown in chondrocytes. Inhibition of matrix degradation and enhancement of formation was observed in chondrocytes cocultured with subchondral osteoblasts preincubated with carnosol indicating a cross-talk between these two cellular compartments, potentially mediated via inhibition of IL-6 in osteoblasts as similar results were obtained with anti-IL-6 ...
Keywords	Medicine ; R ; Science ; Q
Subject code	616
Language	English
Publishing date	2015-01-01T00:00:00Z
Publisher	Public Library of Science (PLoS)
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article: Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases.

Ameye, Laurent / Young, Marian F

Glycobiology

2002 Volume 12, Issue 9, Page(s) 107R–16R

Abstract: Small leucine-rich proteoglycans (SLRPs) are extracellular molecules that bind to TGFbetas and collagens and other matrix molecules. In vitro, SLRPs were shown to regulate collagen fibrillogenesis, a process essential in development, tissue repair, and ... ...

Abstract	Small leucine-rich proteoglycans (SLRPs) are extracellular molecules that bind to TGFbetas and collagens and other matrix molecules. In vitro, SLRPs were shown to regulate collagen fibrillogenesis, a process essential in development, tissue repair, and metastasis. To better understand their functions in vivo, mice deficient in one or two of the four most prominent and widely expressed SLRPs (biglycan, decorin, fibromodulin, and lumican) were recently generated. All four SLRP deficiencies result in the formation of abnormal collagen fibrils. Taken together, the collagen phenotypes demonstrate a cooperative, sequential, timely orchestrated action of the SLRPs that altogether shape the architecture and mechanical properties of the collagen matrix. In addition, SLRP-deficient mice develop a wide array of diseases (osteoporosis, osteoarthritis, muscular dystrophy, Ehlers-Danlos syndrome, and corneal diseases), most of them resulting primarily from an abnormal collagen fibrillogenesis. The development of these diseases by SLRP-deficient mice suggests that mutations in SLRPs may be part of undiagnosed predisposing genetic factors for these diseases. Although the distinct phenotypes developed by the different singly deficient mice point to distinct in vivo function for each SLRP, the analysis of the double-deficient mice also demonstrates the existence of rescuing/compensation mechanisms, indicating some functional overlap within the SLRP family.
MeSH term(s)	Animals ; Corneal Diseases/physiopathology ; Ehlers-Danlos Syndrome/physiopathology ; Leucine/chemistry ; Mice ; Mice, Knockout ; Models, Molecular ; Muscular Dystrophies/physiopathology ; Osteoarthritis/physiopathology ; Osteoporosis/physiopathology ; Proteoglycans/chemistry ; Proteoglycans/genetics ; Proteoglycans/physiology
Chemical Substances	Proteoglycans ; Leucine (GMW67QNF9C)
Language	English
Publishing date	2002-09
Publishing country	England
Document type	Journal Article ; Review
ZDB-ID	1067689-2
ISSN	1460-2423 ; 0959-6658
ISSN (online)	1460-2423
ISSN	0959-6658
DOI	10.1093/glycob/cwf065
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 3150: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Correction: Billeaud et al. “Effects on Fatty Acid Metabolism of a New Powdered Human Milk Fortifier Containing Medium-Chain Triacylglycerols and Docosahexaenoic Acid in Preterm Infants” <i>Nutrients</i> 2018, <i>10</i>, 690

Billeaud, Claude / Ameye, Laurent / Boué-Vaysse, Carole / Couëdelo, Leslie / Cruz-Hernandez, Cristina / Destaillats, Frédéric / Hays, Nicholas P / Jaeger, Jonathan / Picaud, Jean-Charles / Rigo, Jacques / Saliba, Elie / Steenhout, Philippe

Nutrients. 2019 Mar. 22, v. 11, no. 3

2019

Abstract: The authors wish to make a correction to the published version of their paper [ ... ] ...

Abstract	The authors wish to make a correction to the published version of their paper [...]
Keywords	breast milk ; docosahexaenoic acid ; fatty acid metabolism ; medium chain triacylglycerols ; nutrients ; premature birth
Language	English
Dates of publication	2019-0322
Publishing place	Multidisciplinary Digital Publishing Institute
Document type	Article
ZDB-ID	2518386-2
ISSN	2072-6643
ISSN	2072-6643
DOI	10.3390/nu11030680
Database	NAL-Catalogue (AGRICOLA)

Order via subito

To top

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito